Recherche - Urologie CHU Lille

Thématique de recherche

Le service d’Urologie, Andrologie et Transplantation fait partie du Centre Hospitalier Universitaire de Lille et collabore avec la Direction de la recherche et de l’innovation (DRI) du CHU de Lille.

La recherche en oncologie se fait avec la collaboration de :

Imagerie Génito-Urinaire Pr Ph PUECH
Pathologie, Pr X LEROY et S AUBERT
UMR9020-U1277 – CANTHER – Cancer Heterogeneity Plasticity and Resistance to Therapies
D TULASNE et M DUTERQUE
Univ. Lille, CNRS, Inserm, Institut Pasteur de Lille, CHU Lille, , F-59000 Lille, France

La recherche en urologie générale se fait avec la collaboration de

La recherche en Andrologie-Infertilité se fait avec la collaboration de

Les publications des dernières années concernent les articles suivants :

Oncologie

Light A, Lophatananon A, Keates A, Thankappannair V, Barrett T, Dominguez-Escrig J & al , Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance., J Clin Med, 2022
Villers A, Olivier J , Re: Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer., Eur Urol, 2022
Martini A, Touzani A, Beauval JB, Ruffion A, Olivier J, Gasmi A & al , Heterogeneity of contemporary grade group 4 prostate cancer in radical prostatectomy specimens., World J Urol, 2022
Deslandes M, Klein C, Marquette T, Comat V, Mallet R, Degraeve B & al , Influence of holmium laser enucleation of the prostate on erectile function: results of a multicentric analysis of 235 patients., World J Urol, 2022
Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A & al , Risk of progression following a negative biopsy in prostate cancer active surveillance., Prostate Cancer Prostatic Dis, 2022
Rolley C, Barthelemy P, Bensalah K, Nouhaud FX, Villers A, Bruyère F & al , Does the Time to Start First-Line Treatment Influence the Survival of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma? Results of the MetaSurv-UroCCR 79 Study., Clin Genitourin Cancer, 2022
Marenghi C, Qiu Z, Helleman J, Nieboer D, Rubio-Briones J, Carroll PR & al , Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort., Cancers (Basel), 2022
Bommelaere T, Villers A, Puech P, Ploussard G, Labreuche J, Drumez E & al , Risk Estimation of Metastatic Recurrence After Prostatectomy: A Model Using Preoperative Magnetic Resonance Imaging and Targeted Biopsy., Eur Urol Open Sci, 2022 , 24-34
Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM & al , Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative., Eur Urol Open Sci, 2022 , 126-133
Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S & al , Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study., Eur Urol Focus, 2022
Benichou Y, Audenet F, Bensalah K, Roupret M, Paparel P, Lebacle C & al , Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study)., World J Urol, 2022
Stenzl A, Szmulewitz RZ, Petrylak D, Holzbeierlein J, Villers A, Azad A & al , The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups., Prostate, 2022
Armstrong AJ, Azad AA, Iguchi T, Szmulewitz RZ, Petrylak DP, Holzbeierlein J & al , Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer., J Clin Oncol, 2022 , JCO2200193
Benderradji H, Barbotin AL, Leroy-Billiard M, Prasivoravong J, Marcelli F, Decanter C & al , Defining reference ranges for serum anti-Müllerian hormone (AMH) on a large cohort of normozoospermic adult men., J Clin Endocrinol Metab, 2022
Nasri J, Barthe F, Parekh S, Ratnani P, Pedraza AM, Wagaskar VG & al , Nomogram predicting adverse pathology outcome on radical prostatectomy in low-risk prostate cancer men., Urology, 2022
Beckmann KR, Bangma CH, Helleman J, Bjartell A, Carroll PR, Morgan T & al , Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database., Prostate, 2022 , 876-879
Feddal MS, Delporte G, Marcelli F, Villers A , [Urethroplasties for male urethral strictures: Success rates and predictive factors]., Prog Urol, 2022
Kasivisvanathan V, Chan VW, Clement KD, Levis B, Haider M, Agarwal R & al , A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer., PLoS One, 2022 , e0263345
Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V & al , Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium., Eur Urol Open Sci, 2022 , 59-67
Beckmann K, Santaolalla A, Helleman J, Carroll P, Ha Chung B, Shiong Lee L & al , Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database., Eur Urol Open Sci, 2021 , 47-54
Godtman RA, Remmers S, Aus G, Nelen V, van Eycken L, Villers A & al , Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer, Eur. Urol. Open Sci., 2021 , -
Vamour N, Gasmi A, Leroy X, Puech P, Koussa M, Villers A & al , Impact of positive vascular margins status after surgical resection of non-metastatic renal cell carcinoma with caval tumour thrombus: a propensity score multicentre study., World J Urol, 2021
Jarry É, Garot M, Marlière F, Fantoni JC, Villers A, Lebuffe G & al , Predictive factors of postoperative septic complications after flexible ureteroscopy for urinary stones., Prog Urol, 2021
Lopes RD, Higano CS, Slovin SF, Nelson AJ, Bigelow R, Sørensen PS & al , Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial., Circulation, 2021 , 1295-1307
Séguier D, Puech P, Kool R, Dernis L, Gabert H, Kassouf W & al , Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications., Ther Adv Urol, 2021 , 17562872211039583
Azad AA, Armstrong AJ, Alcaraz A, Szmulewitz RZ, Petrylak DP, Holzbeierlein J & al , Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk., Prostate Cancer Prostatic Dis, 2021
Crump RT, Remmers S, Van Hemelrijck M, Helleman J, Nieboer D, Roobol MJ & al , Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients., Transl Androl Urol, 2021 , 2719-2727
Benderradji H, Prasivoravong J, Marcelli F, Barbotin AL, Catteau-Jonard S, Marchetti C & al , Contribution of serum anti-Müllerian hormone in the management of azoospermia and the prediction of testicular sperm retrieval outcomes: a study of 155 adult men., Basic Clin Androl, 2021 , 15
Khadhouri S, Gallagher KM, MacKenzie KR, Shah TT, Gao C, Moore S & al , The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer - a multicentre observational study., BJU Int, 2021
Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, Nieboer D, Bangma C & al , A first step towards a global nomogram to predict disease progression for men on active surveillance., Transl Androl Urol, 2021 , 1102-1109
Nasri J, Beraud F, Seguier D, Delporte G, Behal H, Olivier J & al , Artificial urinary sphincter implantation in non-neurogenic men: a place for out-patient surgery., World J Urol, 2021
Armstrong AJ, Shore ND, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A & al , Reply by Authors., J Urol, 2021 , 101097JU000000000000156802
Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF & al , Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus., Urol Oncol, 2021 , 781.e17-781.e24
Bruinsma SM, Nieboer D, Roobol MJ, Bangma CH, Verbeek JFM, Gnanapragasam V & al , Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative., J Urol, 2021 , 62-68
Marra G, Laguna MP, Walz J, Pavlovich CP, Bianco F, Gregg J & al , Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society., Minerva Urol Nefrol, 2021
Armstrong AJ, Shore ND, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A & al , Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses., J Urol, 2020 , 101097JU0000000000001568
Vesval Q, Fiard G, Villers A, Norris JM, Olivier J , Should we perform systematic biopsies in case of suspicious MRI for prostate cancer in 2020? A review of literature., Prog Urol, 2020
Jarry E, Fantoni J, Puech P, Leroy X, Villers A , , Prog Urol, 2020 , 841
Fantoni J, Puech P, Koussa M, Villers A , , Prog Urol, 2020 , 840-841
Titécat P, Valtille P, Villers A, Olivier J , , Prog Urol, 2020 , 836-837
Coloby P, Occéan B, Chevallier T, Gelet A, Rébillard X, Villers A & al , , Prog Urol, 2020 , 836
Brassier M, Khene Z, Bernhard JC, Nouhaud F, Olivier J, Villers A & al , , Prog Urol, 2020 , 818
Brassier M, Khene Z, Bernhard JC, Nouhaud F, Villers A, Olivier J & al , , Prog Urol, 2020 , 789
Nasri J, Biardeau X, Marcelli F, Villers A, Olivier J , , Prog Urol, 2020 , 780-781
Kaulanjan K, Buisset J, Lecoent Q, Perrot E, Carton M, Multigner L & al , , Prog Urol, 2020 , 775-776
Benichou Y, Bernhard JC, Bensalah K, Roupret M, Dariane C, Paparel P & al , , Prog Urol, 2020 , 751-752
Villers A, Shore N, Armstrong A, Szmulewitz R, Petrylak D, Holzbeierlein J & al , , Prog Urol, 2020 , 745
Rischmann P, Occéan B, Chevallier T, Gelet A, Rébillard X, Villers A & al , , Prog Urol, 2020 , 728-729
Buisset J, Olivier J, Villers A, Norris J, Puech P, Drumez E , , Prog Urol, 2020 , 693-694
Buisset J, Norris JM, Puech P, Leroy X, Ramdane N, Drumez E & al , Negative Pre-biopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Follow-up Results., J Urol, 2020 , 101097JU0000000000001414
Martini A, Falagario UG, Villers A, Dell''''Oglio P, Mazzone E, Autorino R & al , Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy., Eur. Urol., 2020
Villers A, Olivier J , Editorial Comment., J. Urol., 2020 , 101097JU000000000000101501
Tomer A, Nieboer D, Roobol MJ, Bjartell A, Steyerberg EW, Rizopoulos D , Personalized Biopsy Schedules Based on Risk of Gleason Upgrading for Low-Risk Prostate Cancer Active Surveillance Patients., BJU Int., 2020
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF & al , Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer., N. Engl. J. Med., 2020 , 2197-2206
Villers A, Olivier J , Re: Long-term Outcomes of Active Surveillance for Prostate Cancer: The Memorial Sloan Kettering Cancer Center Experience., Eur. Urol., 2020
Houssin V, Olivier J, Brenier M, Pierache A, Laniado M, Mouton M & al , Predictive factors of urinary incontinence after holmium laser enucleation of the prostate: a multicentric evaluation., World J Urol, 2020
Villers A, Bessaoud F, Trétarre B, Grosclaude P, Malavaud B, Rebillard X & al , Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)., Prog. Urol., 2020
Plouvier SD, Bonnal JL, Machuron F, Colin P, Vankemmel O, Leroy X & al , Impact of age on bladder cancer management practices: a general population study., Acta Oncol, 2020 , 1-5
Pagniez MA, Kasivisvanathan V, Puech P, Drumez E, Villers A, Olivier J , Predictive Factors of Missed Clinically Significant Prostate Cancers in Men with Negative MRI: A Systematic Review and Meta-Analysis., J. Urol., 2020 , 101097JU0000000000000757
Barrier A, Marcelli F, Villers A , [Learning curve for inflatable penile prosthesis]., Prog. Urol., 2019
Kalapara AA, Verbeek JFM, Nieboer D, Fahey M, Gnanapragasam V, Van Hemelrijck M & al , Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation''s Global Action Plan Prostate Cancer Active Surveillance Initiative., Eur Urol Oncol, 2020 , 80-91
Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ, Trock B & al , Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts., Eur. Urol., 2019
Saljoghi R, Le Vourch A, Renard B, Villers A, Bouyé S , [Arterial embolization of polycystic kidneys as an alternative to ergonomic nephrectomy in renal pre-transplantation. Monocentric retrospective study]., Prog. Urol., 2019
Armstrong AJ, Szmulewitz RZ, Petrylak DP, Holzbeierlein J, Villers A, Azad A & al , ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer., J. Clin. Oncol., 2019 , JCO1900799
van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Trock B & al , Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies, Eur. Urol. Oncol., 2019 , 333-336
Olivier J, Basson L, Puech P, Lacornerie T, Villers A, Wallet J & al , Stereotactic Re-irradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: Preliminary Results, Front. Oncol., 2019
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V & al , A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer., Eur. Urol., 2019
Clery R, Grande P, Seisen T, Gobert A, Duquesne I, Villers A & al , Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study., World J Urol, 2019
Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P & al , SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer., World J Urol, 2019
Ribout C, Villers A, Ruault S, Bretagnolle V, Picard D, Monceau K & al , Fine-scale genetic structure in a high dispersal capacity raptor, the Montagu''s harrier (Circus pygargus), revealed by a set of novel microsatellite loci., Genetica, 2019
van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR & al , Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project., World J Urol, 2019
Delporte G, Olivier J, Ruffion A, Crouzet S, Cavillon C, Helfrich O & al , [Evolution of the number of incident cases, stage and first treatments for prostate cancer in France between 2001 and 2016]., Prog. Urol., 2019
Mulders PFA, Martinez-Pineiro L, Heidenreich A, Babjuk M, Colombel M, Colombo R & al , Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial, Eur. Focus, 2019 , 849-852
Villers A, Puech P , EDITORIAL COMMENTS, J. Urol., 2020 , 1121-1121

Non-oncologie

Chkir S, Michel F, Akakpo W, Chinier E, Capon G, Peyronnet B, Saussine C, Baron M, Biardeau X, Ruffion A, Gamé X, Denys P, Chartier-Kastler E, Phé V, Karsenty G. Non-continent Urinary Diversion (Ileal Conduit) as Salvage Therapy in Patients With Refractory Lower Urinary Tract Dysfunctions due to Multiple Sclerosis: Results of a National Cohort From the French Association of Urology (AFU) Neurourology Committee and the French-speaking Neurourology Study Group (GENULF). Urology. 2022 Oct;168:216-221. doi: 10.1016/j.urology.2022.06.014. Epub 2022 Jun 26. PMID: 35768028.
de Guerry ML, Demeestere A, Bergot C, de Hauteclocque A, Hascoet J, Bajeot AS, Ternynck C, Gamé X, Peyronnet B, Capon G, Perrouin-Verbe MA, Biardeau X. Adjustable Continence Therapy (ACT®) balloons to treat female stress urinary incontinence: effectiveness, safety and risk factors of failure and complication. Int Urogynecol J. 2022 Jun 25.
Beraud F, Clément G, Lenne X, Biardeau X. Incidence and safety outcomes associated with active stone removal procedures (ASRP): a comparison between neurological and non-neurological patients using the French National Health Data Base. World J Urol. 2022 Jul;40(7):1821-1827.
Hentzen C, Haddad R, Turmel N, Biardeau X, Bey E, Amarenco G, Denys P, Gamé X, Phé V, Peyronnet B, Perrouin-Verbe MA, Joussain C. Priorisation des situations à risque en neuro-urologie : recommandations par méthode Delphi de l’Association française d’urologie (AFU), l’Association francophone internationale des groupes d’animation de la paraplégie (AFIGAP), le Groupe de neuro-urologie de langue française (GENULF), la Société française de médecine physique et de réadaptation (SOFMER) et la Société interdisciplinaire francophone d’urodynamique et de pelvi-périnéologie (SIFUD-PP) [Prioritization of risk situations in neuro-urology: Guidelines based on the Delphi method from Association française d'urologie (AFU), Association francophone internationale des groupes d'animation de la paraplégie (AFIGAP), Groupe de neuro-urologie de langue française (GENULF), Société française de médecine physique et de réadaptation (SOFMER) and Société interdisciplinaire francophone d'urodynamique et de pelvi-périnéologie (SIFUD-PP)]. Prog Urol. 2022 Sep;32(10):635-655. French. doi: 10.1016/j.purol.2022.04.009. Epub 2022 May 31. PMID: 35659166.
Vamour N, Dequirez PL, Seguier D, Vermersch P, De Wachter S, Biardeau X. Early interventions to prevent lower urinary tract dysfunction after spinal cord injury: a systematic review. Spinal Cord. 2022 May;60(5):382-394.
Robin D, Peyronnet B, Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Poussot B, Dupuis H, Tricard T, Hermieu N, Pitout A, Beraud F, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Hermieu JF, Lecoanet P, Capon G, Saussine C, Gamé X, Léon P. Sphincter urinaire artificiel chez les patients présentant une incontinence urinaire après High Intensivity Focused Ultrasound Therapy [Artificial urinary sphincter in patients with urinary incontinence after High Intensity Focused ultrasound]. Prog Urol. 2022 Mar;32(4):284-290. French. doi: 10.1016/j.purol.2021.11.004. Epub 2022 Feb 4. PMID: 35131167.
Mamane J, Sanchez S, Lellouch AG, Gaillard V, Poussot B, Tricard T, Saussine C, Brierre T, Game X, Beraud F, Biardeau X, Bruyere F, Robin D, El-Akri M, Chevallier D, Durand M, Bentellis I, Cousin T, Capon G, Cornu JN, Dupuis H, Monsaint H, Corbel L, Hermieu N, Hermieu JF, Pitout A, Lecoanet P, Peyronnet B, Leon P. Impact of radiation therapy on artificial urinary sphincter implantation in male patients: A multicenter study. Neurourol Urodyn. 2022 Jan;41(1):332-339. doi: 10.1002/nau.24825. Epub 2021 Nov 24. PMID: 34816473.
Demeestere A, de Guerry ML, Bergot C, de Hauteclocque A, Hascoet J, Gamé X, Bajeot AS, Peyronnet B, Capon G, Perrouin-Verbe MA, Biardeau X. Adjustable continence therapy (ACT®) balloons to treat neurogenic and non-neurogenic female urinary incontinence. Neurourol Urodyn. 2021 Oct 11.
de Sallmard G, Perrouin-Verbe MA, Peyronnet B, Biardeau X, Maucort-Boulch D, Chartier-Kastler E, Phé V, Even A, Joussain C, Dominique I, Amarenco G, Gamé X, Saussine C, Ruffion A. Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter. World J Urol. 2022 Feb;40(2):489-495. doi: 10.1007/s00345-021-03850-y. Epub 2021 Oct 9. PMID: 34626226.
Dupuis HGA, Bentellis I, El-Akri M, Brierre T, Cousin T, Gaillard V, Poussot B, Tricard T, Hermieu N, Robin D, Pitout A, Beraud F, Durand M, Chevallier D, Bruyere F, Biardeau X, Monsaint H, Corbel L, Leon P, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Peyronnet B, Cornu JN. Early Efficacy and Safety Outcomes of Artificial Urinary Sphincter for Stress Urinary Incontinence Following Radical Prostatectomy or Benign Prostatic Obstruction Surgery: Results of a Large Multicentric Study. Eur Urol Focus. 2022 Jul;8(4):1053-1059. doi: 10.1016/j.euf.2021.09.006. Epub 2021 Sep 20. PMID: 34548254.
Guillot-Tantay C, Robert G, Ruffion A, Gamé X, Balanca A, Cousin T, Campello PV, Simon J, Baron M, Fleury R, Dequirez PL, Davidson S, Joussain C, Vangheluwe L, Anastay V, Léon P, Perrouin-Verbe MA, Peyronnet B, Biardeau X, Cornu JN, Karsenty G, Phé V. Impact of COVID-19 pandemic on functional urology procedures in France: a prospective study. World J Urol. 2022 Jan;40(1):277-282. doi: 10.1007/s00345-021-03821-3. Epub 2021 Sep 2. PMID: 34476595; PMCID: PMC8412852.
Hentzen C, Biardeau X, Turmel N, Haddad R, Bey E, Amarenco G, et al. Prioritization of risk situations in neuro-urology: guidelines from Association Française d’Urologie (AFU), Association Francophone Internationale des Groupes d’Animation de la Paraplégie (A.F.I.G.A.P.), Groupe de Neuro-urologie de Langue Française (GENULF), Société Française de Médecine Physique et de Réadaptation (SOFMER) and Société Interdisciplinaire Francophone d’UroDynamique et de Pelvi-Périnéologie (SIFUD-PP). World J Urol. 17 août 2021.
Chartier-Kastler E, Normand LL, Ruffion A, Saussine C, Braguet R, Rabut B, Ragni E, Perrouin-Verbe MA, Pierrevelcin J, Rousseau T, Gamé X, Tanneau Y, Dargent F, Biardeau X, Graziana JP, Stoica G, Brassart E, Fourmarier M, Yaghi N, Capon G, Ferchaud J, Berrogain N, Peyrat L, Pecoux F, Bryckaert PE, Melotti A, Abouihia A, Keller DUJ, Cornu JN. Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study. Eur Urol Focus. 2022 Sep;8(5):1399-1407. doi: 10.1016/j.euf.2021.06.013. Epub 2021 Jul 30. PMID: 34334342.
Bentellis I, El-Akri M, Cornu JN, Brierre T, Cousin T, Gaillard V, Dupuis H, Tricard T, Hermieu N, Bertrand-Leon P, Chevallier D, Bruyere F, Biardeau X, Hermieu JF, Lecoanet P, Capon G, Game X, Saussine C, Durand M, Peyronnet B. Prevalence and Risk Factors of Artificial Urinary Sphincter Revision in Nonneurological Male Patients. J Urol. 2021 Nov;206(5):1248-1257. doi: 10.1097/JU.0000000000001954. Epub 2021 Jun 29. PMID: 34184925.
Nasri J, Beraud F, Seguier D, Delporte G, Behal H, Olivier J, Villers A, Marcelli F, Biardeau X. Artificial urinary sphincter implantation in non-neurogenic men: a place for out-patient surgery. World J Urol. 27 march 2021.
Dequirez P-L, Biardeau X. Randomized clinical trials assessing third-line therapies to treat non-neurogenic overactive bladder syndrome: a review about methodology. Int Urogynecol J. 26 march 2021.
Chartier-Kastler E, Le Normand L, Ruffion A, Dargent F, Braguet R, Saussine C, Tanneau Y, Graziana JP, Ragni E, Rabut B, Rousseau T, Biardeau X, Gamé X, Pierrevelcin J, Brassart E, Fourmarier M, Stoica G, Berrogain N, Yaghi N, Pecoux F, Capon G, Ferchaud J, Peyrat L, Bryckaert PE, Karsenty G, Melotti A, Abouihia A, Keller DUJ, Cornu JN. Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study. Eur Urol Focus. 2021 Nov;7(6):1430-1437. doi: 10.1016/j.euf.2020.06.026. Epub 2020 Sep 7. PMID: 32907782.
Bey E, Manach Q, Peyronnet B, Even A, Chartier Kastler E, Walder R, Ruffion A, Baron M, Charlanes A, Biardeau X, Quenneville V, Boillot B, Duport C, Tricard T, Saussine C, Gamé X, Capon G, Kerdraon J, Cornu JN, Garabedian C, Le Normand L, Perrouin-Verbe B, Phe V, Perrouin-Verbe MA. Pregnancy and Delivery in Women with Lower Urinary Tract Reconstruction: A National Multicenter Retrospective Study from the French-Speaking Neuro-Urology Study Group (GENULF) and the Neuro-Urology Committee of the French Association of Urology. J Urol. 2020 Dec;204(6):1263-1269. doi: 10.1097/JU.0000000000001233. Epub 2020 Jul 2. PMID: 32614256.
Biardeau X, Lamande N, Tondut L, Peyronnet B, Verhoest G, Kyheng M, et al. Quality of life associated with orthotopic neobladder and ileal conduit in women: A multicentric cross-sectional study. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2020 Feb 12.
Soust I, Filiette A, Blanchard A, Biardeau X. [Non continent urinary diversion and other bladder managements in patients with multiple sclerosis]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2019 Sep;29(11):572–8.
Biardeau X, Vercleyen S. [Continent cystostomies – indications, surgical technique, complications and management]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2019 Nov;29(15):929–35.
Biardeau X, Haddad R, Chesnel C, Charlanes A, Hentzen C, Turmel N, et al. [Use of botulinum toxin A in pelvic floor dysfunctions in the elderly: A review]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2019 Jan 5;
Guiffart P, Reix B, Martin-Malburet A, Marcelli F, Biardeau X. [Adjustable continence therapy balloons in women: Evolution of efficacy within the 24 months following implantation]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2018 Dec;28(16):927–34.
Biardeau X, Hached S, Loutochin O, Campeau L, Sawan M, Corcos J. Montreal electronic artificial urinary sphincters: Our futuristic alternatives to the AMS800TM. Can Urol Assoc J J Assoc Urol Can. 2017 Oct;11(10): E396–404.
Biardeau X, Lam O, Ba V, Campeau L, Corcos J. Prospective evaluation of anxiety, pain, and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J J Assoc Urol Can. 2017 Apr;11(3-4):104–10.
Biardeau X, Przydacz M, Aharony S, Loutochin G, Campeau L, Kyheng M, et al. Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model. PloS One. 2017;12(1): e0169694.
Shamout S, Biardeau X, Corcos J, Campeau L. Outcome comparison of different approaches to self-intermittent catheterization in neurogenic patients: a systematic review. Spinal Cord. 2017 Jan 24.
Biardeau X, Aharony S, AUS Consensus Group, Campeau L, Corcos J. Artificial urinary sphincter: Report of the 2015 consensus conference. Neurourol Urodyn. 2016 Mar 21.
Biardeau X, Aharony S, AUS Consensus Group, Campeau L, Corcos J. Artificial Urinary Sphincter: Executive Summary of the 2015 Consensus Conference. Neurourol Urodyn. 2016 Apr;35 Suppl 2:S5–7.
Biardeau X, Aharony S, AUS Consensus Group, Campeau L, Corcos J. Overview of the 2015 ICS Consensus Conference. Neurourol Urodyn. 2016 Apr;35(4):437–43.
Biardeau X, Campeau L, Corcos J. We should not use oxybutynin chloride in OAB. Neurourol Urodyn. 2016 Mar 21.
Biardeau X, Corcos J. Intermittent catheterization in neurologic patients: Update on genitourinary tract infection and urethral trauma. Ann Phys Rehabil Med. 2016 Apr 1.
Biardeau X, Elkoushy MA, Aharony S, Elhilali M, Corcos J. Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons. World J Urol. 2015 Jul 28.
Corcos J, Biardeau X, Aharony S. Tips and Tricks in Intra-Detrusor Botulinum Toxin A (BoNTA) Injections. World J Urol. 2015 Jun;33(6):899–901.
Biardeau X, Zanaty M, Aoun F, Benbouzid S, Peyronnet B. [Approach and complications associated with suburethral synthetic slings in women: Systematic review and meta-analysis]. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol. 2015 Sep 1.
Biardeau X, Rizk J, Marcelli F, Flamand V. Reply to Véronique Phé, Morgan Rouprêt, and Emmanuel Chartier-Kastler’s Letter to the Editor re: Xavier Biardeau, Jérôme Rizk, François Marcelli, Vincent Flamand. Robot-assisted Laparoscopic Approach for Artificial Urinary Sphincter Implantation in 11 Women with Urinary Stress Incontinence: Surgical Technique and Initial Experience. Eur Urol 2015;67:937-42. Eur Urol. 2015 Oct 7.
Biardeau X, Rizk J, Marcelli F, Flamand V. Robot-assisted laparoscopic approach for artificial urinary sphincter implantation in 11 women with urinary stress incontinence: surgical technique and initial experience. Eur Urol. 2015 May;67(5):937–42.
Biardeau X, Chartier-Kastler E, Rouprêt M, Phé V. Risk of malignancy after augmentation cystoplasty: A systematic review. Neurourol Urodyn. 2015 Apr 13.
Feddal MS, Delporte G, Marcelli F, Villers A , [Urethroplasties for male urethral strictures: Success rates and predictive factors]., Prog Urol, 2022
Benderradji H, Barbotin AL, Leroy-Billiard M, Prasivoravong J, Marcelli F, Decanter C & al , Defining reference ranges for serum anti-Müllerian hormone (AMH) on a large cohort of normozoospermic adult men., J Clin Endocrinol Metab, 2022
Benderradji H, Prasivoravong J, Marcelli F, Barbotin AL, Catteau-Jonard S, Marchetti C & al , Contribution of serum anti-Müllerian hormone in the management of azoospermia and the prediction of testicular sperm retrieval outcomes: a study of 155 adult men., Basic Clin Androl, 2021 , 15
Jarry É, Garot M, Marlière F, Fantoni JC, Villers A, Lebuffe G & al , Predictive factors of postoperative septic complications after flexible ureteroscopy for urinary stones., Prog Urol, 2021
Hénon F, Le Nobin J, Ouzzane A, Villers A, Strecker G, Bouyé S , Factors influencing the choice of nondonor families in a French organ-harvesting center, Prog. Urol., 2016 , 656-661